LLY · XBRL financial data

ELI LILLY and Company financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LLY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	24,540	28,318	28,541	34,124	45,043	65,179
Cost of goods and services sold	5,483	7,313	6,630	7,082	8,418	11,052
Research and development	6,086	7,026	7,191	—	—	—
Selling, general and administrative	6,121	6,432	6,440	7,403	8,594	11,094
Interest income	33	25	63	174	175	—
Interest expense	360	340	332	486	781	895
Other income (expense)	1,247	51	(14)	(33)	(25)	—
Income tax expense (benefit)	1,036	574	562	1,314	2,090	5,091
Net income (loss)	6,194	5,582	6,245	5,240	10,590	20,640
Earnings per share, basic USD per share	6.82	6.15	6.93	5.82	11.76	23.00
Earnings per share, diluted USD per share	6.79	6.12	6.90	5.80	11.71	22.95
Weighted average shares, basic millions of shares	908	907	902	900	901	897
Weighted average shares, diluted millions of shares	913	912	905	903	904	899

Fiscal years (LLY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	3,657	3,819	2,067	2,819	3,268	7,268
Short-term investments	24	90	145	109	155	—
Accounts receivable	5,875	6,673	6,896	9,091	11,006	17,760
Inventory	3,980	3,886	4,310	5,773	7,589	13,744
Prepaid and other current assets	—	2,531	2,954	—	—	—
Total current assets	17,462	18,452	18,035	25,727	32,740	55,629
Property and equipment, net	8,682	8,985	10,144	12,914	17,102	24,675
Right-of-use asset	—	—	—	1,024	1,050	1,260
Goodwill	3,767	3,892	4,073	4,940	5,770	5,898
Total assets	46,633	48,806	49,490	64,006	78,715	112,476
Accounts payable	1,607	1,671	1,931	2,599	3,229	5,379
Commercial paper	0	0	1,498	6,189	4,338	0
Total current liabilities	12,482	15,053	17,138	27,293	28,377	35,228
Long-term debt	16,587	15,346	14,738	18,321	28,527	40,868
Lease liability, non-current	—	—	—	949	971	1,140
Retained earnings	7,830	8,959	10,043	10,312	13,545	24,470
Total stockholders' equity	5,642	8,979	10,650	10,772	14,192	26,535
Total liabilities and equity	46,633	48,806	49,490	64,006	78,715	112,476
Common shares outstanding (cover page) millions of shares	958	952	950	950	948	943

Fiscal years (LLY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	6,194	5,582	6,245	5,240	10,590	20,640
Stock-based compensation	308	343	371	629	646	626
Depreciation and amortization	1,324	1,548	1,523	1,527	1,767	1,997
Net cash from operating activities	6,500	7,261	7,084	4,240	8,818	16,813
Net cash from investing activities	(2,259)	(2,762)	(3,262)	(7,153)	(9,302)	(10,972)
Share repurchases	500	1,250	1,500	750	2,500	4,108
Dividends paid	2,687	3,087	3,536	4,069	4,680	5,384
Proceeds from long-term debt	2,062	2,411	0	3,959	11,417	13,167
Repayments of long-term debt	277	1,905	1,560	0	664	778
Net cash from financing activities	(3,137)	(4,131)	(5,407)	3,496	1,230	(2,213)
Net change in cash	1,320	161	(1,752)	752	450	4,000

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Eli Lilly	4,885	24,397	11,397*	940.7M	Q3 FY26 10-QSep 30, 2026
Johnson & Johnson	16,910	25,399	7,720*	2.4B	Q3 FY26 10-QSep 27, 2026
AbbVie	10,774	17,404	7,606*	1.8B	Q3 FY26 10-QSep 30, 2026
Abbott Laboratories	4,052	13,013	1,737*	1.7B	Q3 FY26 10-QSep 30, 2026
Merck	9,550	18,085	6,558*	2.5B	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 5, 2026, 9:37 PM ET. The filing on SEC.gov is the record.